467 469 Bellj4 CV
User Manual: 467-469
Open the PDF directly: View PDF 
.
Page Count: 6
| Download | |
| Open PDF In Browser | View PDF |
Curriculum Vitae PERSONAL INFORMATION James Bell WORK EXPERIENCE April 2009–Present Consultant Physician South london and maudsley NHS Foundation Trust, (United Kingdom) patient care, management, research, teaching Related document(s): March 1996–April 2009 Director, The Langton Centre South eastern Sydney Area Health Service, (Australia) Addiction medicine Leadership and management of service Research Teaching Related document(s): EDUCATION AND TRAINING January 1988–December 2001 MD University of New South Wales, (Australia) Opioid Substitution treatment Related document(s): January 1982–March 1985 FRACP Royal Australasian college of Physicians, (Australia) Internal medicine Related document(s): ADDITIONAL INFORMATION Expertise Opioid Substitution treatment management of Addiction Publications Read R, Bell J, Batey R (1984) Cardiac function assessed by gated heart pool studies in an alcohol clinic population: a preliminary study. Alcoholism: Clinical and Experimental Research, 8; 5: 467-469 Bell J, Seres V, Bowran P, et al (1988) The use of serum methadone levels in patients on methadone maintenance. Clinical Pharmacology and Therapeutics, 43; 6: 623-630 Bell J, The E, Patel A, et al (1988) The identification of at-risk drinking in a teaching hospital. Medical Journal of Australia, 149; 351-355 Bell J, Cumming R (1989) Drinking habits in Sydney's western suburbs. Australian Drug & Alcohol Review, 8; 1: 9-14 Dwyer D, Bell J, Batey R, et al (1989) Low prevalence of human immunodeficiency virus infection in methadone programme attenders and pregnant intravenous drug users in the western metropolitan region of Sydney. Australian and New Zealand Journal of Medicine, 19; 407-408. Bell J, Fernandes D, Batey R (1990) Heroin users seeking methadone treatment. Medical Journal of 3/6/14 © European Union, 2002-2014 | http://europass.cedefop.europa.eu Page 1 / 6 Curriculum Vitae James Bell Australia, 152; 361-364 Bell J, Bowran P, Lewis J, Batey R (1990) Serum methadone levels in maintenance patients who persist in illicit drug use. British Journal of Addiction, 85; 12: 1599-1602 Bell J, Batey R, Crewe E, Cunningham A, Farrell G, Byth K (1990) Hepatitis C in intravenous drug users. Medical Journal of Australia, 153; 274-276 Caplehorn J, Bell J (1991) Methadone dosage and retention in maintenance treatment. Medical Journal of Australia, 154; 195-199 Bell J (1991) Pain and addiction. Drug and Alcohol Review 1991, 10; 247-252 Bell J (1991) The prevalence of at-risk drinking in general hospitals. Clinical Biochemist Monograph No. 5, 31-33 Bell J, Wyndham L, (eds). Screening for drug abuse - a community challenge. Clinical Biochemist Monograph No. 5, 1991. Bell J, Batey R (1992) Medicine and the addictions. Australian and New Zealand Journal of Medicine, 22; 202-203 Bell J, DiGiusto E, Byth K (1992) Who should receive methadone maintenance? British Journal of Addiction, 87; 689-694 Bell J, Hall W, Byth K (1992). Changes in criminal activity after entering methadone maintenance. British Journal of Addiction, 87; 251-258 Bell J (1992) Treatment dependence: preliminary description of yet another syndrome. British Journal of Addiction, 87; 1049-1054 Caplehorn J, Bell J, Kleinbaum A, Gebski V (1993) Methadone dose and heroin use during maintenance treatment. Addiction, 88; 119-124 Hall W, Bell J, Carless J (1993) Crime and drug use among applicants for methadone maintenance. Drug and Alcohol Dependence, 31; 123-129 Robertson M, Bell J (1993) Are rapid benzodiazepine detoxifications unsafe? (letter to the editor) Medical Journal of Australia, 158; 578-579 Bell J, Caplehorn J, McNeil D (1994) The effect of intake procedures on performance in methadone maintenance. Addiction, 463-472 Bell J, Chan J, Kuk A (1995) Investigating the effect of treatment philosophy on outcome of methadone maintenance. Addiction, 90; 823-830 Bell J (1995) Lessons from a training programme for methadone prescribers. Medical Journal of Australia, 162; 143-144 Howard K, Bell J, & Christie M (1995) Measuring drug use in methadone maintenance programmes. Drug and Alcohol Review, 14; 27-34 Bell, J (1995) Codependency (letter) Drug and Alcohol Review, 14; 240-241 Bell J, Ward J, Mattick RP, Hay A, Chan J, and Hall W (1995) An evaluation of private methadone clinics. National Drug Strategy Research Report No 4, Australian Government Publishing Service, Canberra Bell J (1996) Alternatives to non-clinical regulation; training doctors to prescribe methadone. Addiction Research, 3; 4: 315-322 Bell J (1996) Why do people use drugs? in, Wilkinson, C., and Saunders, B. (eds) Perspectives On Addiction. William Montgomery Press, Perth Ward J, Bell J, Mattick P, and Hall W (1996) Methadone maintenance therapy for opioid dependence; a guide to appropriate use. CNS Drugs, 6: 6; 440-449 Bell, J (1997) Australian trends in opioid prescribing for chronic, non-cancer pain, 1986-1996. Medical Journal of Australia 167; 26-29 Bell J, Mattick RP, Chan J, Hay A, Hall W (1997) Methadone maintenance and drug related crime. Journal of Substance Abuse Treatment 9; 15-25 Chan JSK, Kuk AYC & Bell J (1997) A likelihood approach to analysing longitudinal bivariate binary data. Biometrical Journal 39 (4), 409-421 Bell, J (1998) Delivering effective methadone treatment. In Ward, J., Mattick, R.P., and Hall, W. (eds) Methadone Maintenance Treatment and Other Opioid Replacement Therapies Harwood Academic Publishers, Amsterdam Bell J (1998) Staff training in methadone clinics. In Ward, J., Mattick, R.P., and Hall, W. (eds) Methadone Maintenance Treatment and Other Opioid Replacement Therapies Harwood Academic 3/6/14 © European Union, 2002-2014 | http://europass.cedefop.europa.eu Page 2 / 6 Curriculum Vitae James Bell Publishers, Amsterdam Chan JSK, Kuk AYC, Bell J, & McGilchrist C (1998) The analysis of methadone clinic data using marginal and conditional logistic models with mixture or random effects. The Australian and New Zealand Journal of Statistics, 40 (1): 1-10 Bell J (1998) Self report among injecting drug users. Drug and Alcohol Dependence 51; 267-268 Cadman M & Bell J (1998) Doctors detected self-administering opioids in New South Wales, 19851994; characteristics and outcomes. Medical Journal of Australia 169; 419-421 Mattick RP, Bell J, Daws LC, White JM, O’Brien S, & Harris S (1998) Review of the effectiveness of antagonists in managing opioid dependence. NDARC Monograph #34, National Drug and Alcohol Research Centre, Sydney Bell J, Young M, Masterman S, Morris A, Mattick RP, & Bammer G (1999) A pilot study of naltrexoneaccelerated detoxification in opioid dependence. Medical Journal of Australia, 171; 26-30 McKetin R, Ward PB, Catts SV, Mattick RP, Bell J (1999) Changes in Auditory Selective Attention and Even-Related Potentials Following Oral Administration of D-amphetamine in Humans. Neuropsychopharmacology, 21 (3); 380-390 Bell J & Zador D (2000) A risk-benefit analysis of methadone maintenance treatment. Drug Safety 22 (3); 179-190 Bell J (2000) Quality improvement for methadone maintenance treatment. Substance Use and Misuse 35; 1735-1756 Glasgow NJ, Taylor J, Bell J, Young M, & Bammer G (2001) Accelerated withdrawal from methadone maintenance therapy using naltrexone and minimal sedation: a case series analysis. Drug and Alcohol Review, 20 (2) 213-222 Nilssen O, Parker G, Hadzi-Pavlovic D, Bell J (2001) Assessing depression in drug and alcoholdependent patients; the utility of a cognitive-based approach. Nordic Journal of Psychiatry 55(6); 409412 Bell J, Dru A, Fischer B, Levit S, & Sarfraz, MA (2002) Substitution therapy for heroin addiction Substance Use and Misuse 37 (8-10); 1145-1174 Dean AJ, Bell J, Mascord DJ, Parker G, & Christie MJ. (2002) A randomised, controlled trial of fluoxetine in methadone maintenance patients with depressive symptoms. Journal of Affective Disorders, 72; 85-90 Lintzeris N, Bell J, Bammer G, Jolly D, & Rushworth L (2002) A randomised, controlled trial of buprenorphine in the management of short-term ambulatory heroin withdrawal. Addiction, 97; 13951404 Breen CL, Harris SJ, Lintzeris N, Mattick RP, Hawken L, Bell J, Ritter AJ, Lenne M, & Mendoza E (2003) Cessation of methadone maintenance treatment using buprenorphine: transfer from methadone to buprenorphine and subsequent buprenorphine reductions. Drug and Alcohol Dependence 71; 49-55 Gibson AE, Doran CM, Bell JR, Ryan A, & Lintzeris M (2003) A comparison of buprenorphine treatment in specialist and primary care settings: a randomised trial. Medical Journal of Australia179; 38-42 Doran CM, Shanahan M, Mattick RP, Ali R, White J, Bell J (2003). Buprenorphine versus methadone maintenance: a cost-effectiveness analysis Drug and Alcohol Dependence 71; 3: 295-302 Sue Henry-Edwards, Linda Gowing, Jason White, Robert Ali, James Bell, Rodger Brough, Nick Lintzeris, Alison Ritter, Allan Quigley (2003) Clinical Guidelines and Procedures for the Use of Methadone in the Maintenance Treatment of Opioid Dependence Australian Government Department of Health and Ageing, Canberra Bell J, Kimber J, Lintzeris N, White J, Monheit B, Henry-Edwards S, Mattick R, Ali R, Ritter A, Quigley A (2003) Clinical Guidelines and Procedures for the Use of Naltrexone in the Management of Opioid Dependence Commonwealth department of Health and Aging, Canberra Rea F, Bell J, Young M, & Mattick R (2004). A randomised, placebo-controlled trial of different dose levels of naltrexone for the treatment of opioid dependence Drug and Alcohol Dependence 75; 79-88 Doran CM, Shanahan M, Bell J, et al. (2004) A cost-effectiveness analysis of buprenorphine-assisted heroin withdrawal DRUG AND ALCOHOL REVIEW 23; 2: 171-175 Bell J, Byron G, Gibson A, & Morris A (2004) A pilot study of buprenorphine-naloxone combination tablet (Suboxone) in treatment of opioid dependence. Drug and Alcohol Review 23; 311-317 Dean AJ, Bell JR, Christie M, & Mattick RP (2004) Depressive symptoms during buprenorphine 3/6/14 © European Union, 2002-2014 | http://europass.cedefop.europa.eu Page 3 / 6 Curriculum Vitae James Bell versus methadone maintenance: Findings from a randomized, controlled trial in opioid dependence. European Psychiatry 19; 510-513 Digiusto E, Lintzeris N, Breen C, Kimber J, Mattick RP, Bell J, Ali R, Saunders JB, the NEPOD Research Group. (2005). Short-term outcomes of five heroin detoxification methods in the Australian NEPOD Project. Addictive Behaviors, 2005, 30, 443-456 Bell J, Burrell T, Indig D, & Gilmour S (2006) Cycling in and out of treatment; participation in methadone treatment in NSW, 1990-2002 Drug and Alcohol Dependence 81; 55-61 Bell J & Burrell T (2006) Retention and attendance with Supervised Buprenorphine Treatment; a case note review Drug and Alcohol Review 25; 161-165 Bell J & Mutch C (2006) Treatment retention in adolescent patients treated with methadone or buprenorphine for opioid dependence; a file review Drug and Alcohol Review 25; 167-171 Shanahan, M.D., Doran, C.M., Digiusto, E., Bell, J., Lintzeris, N., White, J.M., Ali, R., Saunders, J.B., Mattick, R.P. and Gilmour, S. (2005). A cost-effectiveness analysis of heroin detoxification methods in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD). Addictive Behaviors, 31, 371-387. Bell J & Dunlop A (2006) Managing opioid dependence in pregnant women. In, NSW Dept of Health Managing opioid dependence in pregnant women Background papers to the National clinical guidelines for the management of drug use during pregnancy, birth, and the early development years of the newborn. NSW Dept of Health, Sydney Morley K, Teesson M, Reid S, Sannibale C, Thomson C, Phung Nghi, Weltman M, Bell J, Richardson K, Haber P (2006) Naltrexone versus acamprosate in the treatment of alcohol dependence; a multicentre, randomized, double-blind, placebo-controlled trial Addiction 101 (10); 1451-1462 Winstock A.R., Bell J. Clinical Guidelines, Assessing suitability for unsupervised medication doses in the treatment of opioid dependency. The Royal Australasian College of Physicians, Adult Medicine Division, Australasian Chapter of Addiction Medicine 2006 . Available at: http://www.racp.edu.au/page/about-the-racp/structure/australasian-chapter-of-addictionmedicine Milne B, Bell J, Lampropoulos B and Towns S (2007) Alcohol, drugs and Australian young people. International Journal of Adolescent Medicine and Health 19 (3):245-53 Ryan G, Lyon P, Kumar K, Bell J, Barnet S, Shaw T (2007) Online CME: An effective alternative to face-to-face delivery. Medical Teacher 29(8):e251-7, Oct. Bell J, Shanahan M, Mutch C, Rea F, Ryan A, Batey R, Dunlop A, Winstock A (2007) A randomised trial of effectiveness and cost effectiveness of observed versus unobserved administration of buprenorphine-naloxone for heroin dependence Addiction 102; 1899-1907 Bell J (2007) Commentary on Geppert et al.: ‘Development of a bibliography on religion, spirituality and addictions Drug and Alcohol Review 26; 435-36 Bell J and Zador D (2007) Dihydrocodeine as effective as methadone for maintenance of treatment for opiate dependence? Commentary on Robertson et al. Evidence-Based Mental Health 10; 88 Bell, J. (2007). The role of supervision of dosing in opioid maintenance treatment. Paper presented at the Background document prepared for 3rd meeting of Technical Development Group, for the WHO Guidelines for Psycho-socially Assisted Pharmacotherapy of Opioid Dependence . Geneva, 17-21 September 2007. Bell J & Harvey-Dodds L (2008) Pregnancy and injecting drug use BMJ 336; 1303-1305 Bell J, Ryan A, Mutch C, Batey R, Rea F (2008) Optimising the benefits of unobserved dose administration for stable opioid maintenance patients: Follow-up of a randomised trial, Drug Alcohol Dependence 96:1/2, 183-186 Bell J (2008) Speciality Recognition of Addiction Medicine in Australia (editorial) Addiction, 103, 701– 702 Bell J & Butler B (2008) Health care utilization and morbidity associated with methadone and buprenorphine treatment Heroin Addiction and Related Clinical Problems 10(2); Bell J, Trinh L, Butler B, Randall D, Rubin G (2009) Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment Addiction 104; 1193-1200 Burns, L Randall DA, Hall WD, Law MG, Butler AG, Bell JR, Degenhardt L (2009) Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: Patient characteristics and patterns and predictors of treatment retention Addiction. 104(8):1363-72 Bell J, Butler B, Lawrance A, Batey R, Salmelainen P (2009) Comparing overdose mortality 3/6/14 © European Union, 2002-2014 | http://europass.cedefop.europa.eu Page 4 / 6 Curriculum Vitae James Bell associated with methadone and buprenorphine treatment Drug and Alcohol Dependence 104; 1-2:7377 Bell J (2009) Politics, Practice and Research into the Treatment of Heroin Addiction, in Mattick, Ali and Lintzeris (eds) Pharmacotherapies for the Treatment of Opioid Dependence Informa Health care, New York, pp330-353 Lintzeris N, Gowing L, and Bell J (2009) Services for heroin withdrawal, in Mattick, Ali and Lintzeris (eds) Pharmacotherapies for the Treatment of Opioid Dependence Informa Health Care, New York, pp54-106 Jason White, James Bell, John B. Saunders, Paul Williamson, Maria Makowskac, Aaron Farquharson, Katherine L. Beebe (2009) Open-label Dose-Finding Trial of Buprenorphine Implants (Probuphine)® for Treatment of Heroin Dependence Drug and Alcohol Dependence 103; 37-43 Bell, J., Shearer, J., Ryan, A., Graham, R., Korompay, K., Rizzo, S., Sindhusake, D., & Somogyi, AA (2009) The acceptability, safety and tolerability of methadone/naloxone in a 50:1 ratio Experimental and Clinical Psychopharmacology 17:3; 146153 Degenhardt, L., Larance, B., Bell, J., Winstock, A., Lintzeris, N., Ali, R., Scheuer, N., & Mattick, R. (2009). Injection of OST in Australia following the introduction of a mixed partial agonist-antagonist opioid medication Med J Aust 191 (3): 161-165 Mammen K and Bell J (2009) The clinical efficacy and abuse potential of combination buprenorphine– naloxone in the treatment of opioid dependence Expert Opinion in Pharmacotherapy 2009, Vol. 10, No. 15, Pages 2537-2544 Larance B, Degenhardt L, Mattick R, O’Brien S, Lintzeris N, Bell J, Winstock A and Ali R (2009) The diversion and injection of the pharmaceutical opioids used in opioid substitution treatment: Findings from the Australian post-marketing surveillance studies of buprenorphine-naloxone, 2006-2008 Technical report no. National Drug and Alcohol Research Centre, Sydney Bell, J (2010) Culture, treatment, and the culture of treatment (Commentary), Addiction 105; 16-17 Shearer, J., Mammen, K., & Bell, J. (2010) The acceptability of combined methadone-naloxone treatment: consumer and provider views on the potential utility of methadone-naloxone Drug and Alcohol Review 29; 138-143 Bell J (2010) The global diversion of pharmaceutical drugs. Opiate treatment and the diversion of pharmaceutical opiates: a clinician’s perspective. Addiction 105(9):1531-7 Bell J & Collins R (2011) Gamma-butyrolactone (GBL) dependence and withdrawal Addiction 106(2); 442-447 Butler B, Bell J, Rubin G, Lawrance A, Batey R (2010) Estimating the risk of fatal arrhythmia in patients in methadone maintenance treatment for heroin addiction Drug and Alcohol Review DOI: 10.1111/j.1465-3362.2010.00213.x Larance B, Degenhardt L, O’Brien S, Lintzeris N, Winstock A, Mattick RP, Bell J, and Ali R (2011) Prescribers' perceptions of the diversion and injection of medication by opioid substitution treatment patients D&A Review 30; 6: 613-20 Bell J (2011) Your guide to today's mental health issues. Managing drug problems. Mental Health Today: 25-7 Dean AJ. Saunders JB. Bell J (2011) Heroin use, dependence, and attitudes to treatment in nontreatment-seeking heroin users: a pilot study Substance Use & Misuse. 46(4):417-25 Webzell I, Ball D, Bell J, Sherwood RA, Marsh A, O'Grady JG, Heaton ND (2011) Substance use by liver transplant candidates: an anonymous urinalysis study. Liver Transplantation Oct;17(10):1200-4. doi: 10.1002/lt.22370 Bell, J., Reed, K., Ashcroft, R., Witton, J. and Strang J. Treating opioid dependence with opioids: exploring the ethics Chapter 3, pp 57-74. In: Addiction Neuroethics, Carter, A., Hall, W. and Illes, J. (Eds). Academic Press, 2012 Bell J, Bowler S, Lyons J (2012) Urgent Issues of Alcohol Overload Health Services Journal 5th January, pp26-27 Frewen A, Molan J, Ritter A, Bell J (in press) Uncovering a new approach to developing clinical based guidelines: the experience of developing guidelines for management of drug dependent women and neonates and for cannabis dependence Journal of Person Centred Medicine Bell J, Kilic C, Prabakaran R, Wang Y, Wilson R, Broadbent M, Kumar A, Curtis V (2013) Can use of the electronic health record improve identification of drug and alcohol misuse among psychiatric inpatients? The Psychiatrist 37; 15-20 3/6/14 © European Union, 2002-2014 | http://europass.cedefop.europa.eu Page 5 / 6 Curriculum Vitae James Bell Bell J (2012) Buprenorphine in the treatment of heroin addiction Düşünen Adam The Journal of Psychiatry and Neurological Sciences 25; 93-100 Bell J (2012) Alcohol Use Disorders Medicine 40; 637-639 Bell J (2012) Opioid Substitution treatment and its effectiveness; review of the evidence National Treatment Agency, London Bell J (2012) Maintenance Pharmacological Treatment of Opiate Dependence British Journal of Clinical Pharmacology DOI: 10.1111/bcp.12051 Bell J, Reed K, Gross S, Witton J (2013) The Management of Pain in people with a past or current history of addiction Action on Addiction, London Bell J, Healey C, Kennedy F, Shah A, Faizal M (2013) Evidence and recovery; improving outcomes in opiate substitution treatment British journal of Medical practice 6:1; a601 Reed K and Bell J Reducing secondary health harms and social problems in Drugs of addiction: what can the medical profession do? British Medical Association, London Bell J and Reed K (2013) Doctor’s role in managing heroin addiction, in Drugs of addiction: what can the medical profession do? British Medical Association, London Winstock, A., Bell, J., Borschmann, R. (2013). Friends, doctors and tramadol: We might have a problem BMJ 347:doi:10.1136/bmj.f5586 http://www.bmj.com/content/347/bmj.f5108?tab=responses Winstock, A., Bell, J., Borschmann, R. (2014) The non-medical use of tramadol in the UK: findings from a large community sample International Journal of drug Policy in press Projects Consultant, UNODC/WHO, Albania 2012 Review of OST Program Consultant, UNODC, Bulgaria 2013 Review of OST Program Consultant, UNODC/WHO Evaluation of OST Project, Pakistan Memberships Other Relevant Information 3/6/14 © European Union, 2002-2014 | http://europass.cedefop.europa.eu Page 6 / 6
Source Exif Data:
File Type : PDF File Type Extension : pdf MIME Type : application/pdf PDF Version : 1.4 Linearized : No Page Count : 6 Producer : iText® 5.4.0 ©2000-2012 1T3XT BVBA (AGPL-version) Modify Date : 2014:06:03 10:04:46+01:00 Create Date : 2014:06:03 10:04:46+01:00EXIF Metadata provided by EXIF.tools